BioCancell Therapeutics Inc (BICL.TA)

Not featured in screeners

Not featured in screeners

Ticker: BICL.TA

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

Clal Biotechnology Industries Ltd.

1 purchase — total 2,328,785 USD

Buy 31 Jul 2012

Value US$2,928,870.74 | Price 252.47 | Shares 45,928

Clal Biotechnology Industries Ltd.

1 purchase — total 2,131,844 USD

Buy 24 Jan 2012

Value US$3,719,400.23 | Price 251.86 | Shares 67,902

Boim Aviv

1 purchase — total 400,231,500,000 USD

Buy 31 Jul 2008

Value US$400,231,500,000.00 | Price 500,000.00 | Shares 800,463

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2012-08-07	2012-07-31	B Purchase	Clal Biotechnology Industries Ltd. Large shareholder	45,928 -19.2% 252.47 US$2,928,871	45,928 -19.2%	252.47	US$2,928,871
2012-03-07	2012-01-24	B Purchase	Clal Biotechnology Industries Ltd. Large shareholder	67,902 -41.8% 251.86 US$3,719,400	67,902 -41.8%	251.86	US$3,719,400
2010-08-30	2008-07-31	B Purchase	Boim Aviv Non-Executive Director Large shareholder	52,664 +33.9% 476.26 US$3,407,217	52,664 +33.9%	476.26	US$3,407,217

More insider trading research around BioCancell Therapeutics Inc